tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PremiumRatingsPromising Developments at Contineum Therapeutics Signal Undervaluation and Favorable Risk-Reward
2M ago
Premium
Company Announcements
Contineum Therapeutics Reports Q1 2025 Financial Results
2M ago
Premium
Company Announcements
Contineum Therapeutics Files $300M Shelf Registration
2M ago
PremiumCompany AnnouncementsContineum Therapeutics Appoints Diego Miralles to Board
4M ago
Premium
Ratings
Buy Rating for Contineum Therapeutics: Promising Pipeline and Market Opportunities
4M ago
Contineum initiated with a Buy at JonesResearch
Premium
The Fly
Contineum initiated with a Buy at JonesResearch
4M ago
Contineum initiates dosing in phase 1b Chronic Pain trial of PIPE-791
PremiumThe FlyContineum initiates dosing in phase 1b Chronic Pain trial of PIPE-791
5M ago
Contineum initiates patient dosing in Phase 1B PET trial
Premium
The Fly
Contineum initiates patient dosing in Phase 1B PET trial
7M ago
Premium
Company Announcements
Contineum Therapeutics: Q3 2024 Financial Overview
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100